price list 2018 - genefast

GENEFAST SRL Via Jolanda Baldassari 6, 47122 Forlì (FC) . Tel. 0543/705473 . Fax 0543/805270 . P.IVA 02851890364 . [email protected] . www.genefast.com

1

PRICE LIST 2018


2

Table of Contents

• Abbreviations used ……………………………………….…..………………….…… 3

• Infectious disease PCRs/Dogs …………………………………………………..… 3

• Infectious disease PCRs/Cats ………………………..……………………………. 5

• Infectious disease PCRs/Horses …………………….…………………………..… 6

• Infectious disease PCRs/Pigs and Cattle ..…………………..…….………….. 7

• Infectious disease PCRs/Birds and Rabbits ……………….……….………….. 7

• Infectious disease PCR profiles …………………………………….…………....… 7

• Genetic diseases ………………………………………………………….………..…... 9

• Genetic disease profiles/Dogs and Cats ……………..…………....….....….. 14

• Veterinary molecular oncology/diseases …………...……………….…...… 16

• Immunofluorescence Serology/diseases …………….………………..….… 17

• Immunofluorescence Serology/disease profiles …….…………….......... 18


3

Abbreviations used

AH = aqueous humour

@B/C = biopsy/cytology

BAL = bronchoalveolar/tracheal lavage

BM = bone marrow

BS = buccal swab

CS = cloacal swab

CSF = cerebrospinal fluid

CSW = conjunctival swab

EB = EDTA blood

EBS = EDTA blood swab

F = feathers

FC = feces

FS = faecal swab

JF= joint fluid

NS = nasal swab

OSP = oropharyngeal swab

PL = plasma

S = swab

SE = serum

SP = sperm

T = tissue

F/VS = foreskin/vaginal swab

U = urine

INFECTIOUS DISEASE PCRS/Dogs

T e s t A b b r e v i a t io n s Analysis

M a x i m u m

t u r n a r o u n d

t i m e

P r i c e i n

e u r o s V A T

i n c l .

8 5 A c a n t h a m o e b a s p p B / C Real-time PCR 1 - 2 g g 5 3 , 6 8

2 4 A n a p l a s m a p h a g o c y t o p h i l u m E B , B / C , C S F Real-time PCR 1 - 2 g g 5 3 , 6 8

7 0 A n a p l a s m a p l a t y s E B , B / C , C S F PCR 1 - 2 g g 5 3 , 6 8

8 6 A n g i o s t r o n g i l u s v a s o r u m E B Real-time PCR 1 - 2 g g 5 3 , 6 8

1 3 6 A n t i b i o t i c r e s i s t a n c e ( M R S A ) E B PCR 1 - 2 g g 3 6 , 6 0

3 B a b e s i a c a n i s B / C , E B Real-time PCR 1 - 2 g g 5 3 , 6 8

2 5 0 B a b e s i a g i b s o n i B / C , E B Real-time PCR 1 - 2 g g 5 3 , 6 8

3 6 B o r d e t e l l a b r o n c h i s e p t i c a N S , B A L Real-time PCR 1 - 2 g g 4 6 , 9 7

2 5 B o r r e l i a b u r g d o r f e r i i E B , C S F , J F

Real-time TaqMan®

PCR 1 - 2 g g 4 6 , 9 7

3 7 C A V 2 ( c a n i n e a d e n o v i r u s t y p e 2 ) N S , O S P , B A L , F C Real-time PCR 1 - 2 g g 4 6 , 9 7

3 2 C C O V ( c a n i n e c o r o n a v i r u s ) F C RT Real-time PCR 1 - 2 g g 5 3 , 6 8

1 3 5 C a r b a p e n e m a n t i b i o t i c r e s i s t a n c e E B PCR 1 - 2 g g 6 1 , 0 0

1 3 7 C e s t o d a s p p F C PCR 1 - 2 g g 4 6 , 9 7

6 0 7 C l o s t r i d i u m b o t u l i n u m c o n t a c t l a b PCR 1 - 2 g g 8 0 , 5 2

3 5 C r y p t o s p o r i d i u m s p p . F C Real-time PCR 1 - 2 g g 5 3 , 6 8

1 0 0 C y t a u x z o o n F C PCR 1 - 2 g g 4 6 , 9 7

2 6 D i r o f i l a r i a i m m i t i s E B , B / C Real-time PCR 1 - 2 g g 4 0 . 2 6

2 7 D i r o f i l a r i a r e p e n s E B , B / C Real-time PCR 1 - 2 g g 4 0 . 2 6

6 D i s t e m p e r C S F , E B , O S P RT Real-time PCR 1 - 2 g g 5 1 , 2 4

9 E h r l i c h i a ( A n a p l a s m a ) s p p . E B , B / C , C S F Real-time PCR 1 - 2 g g 5 3 , 6 8

1 0 E h r l i c h i a c a n i s E B , B / C , C S F Real-time PCR 1 - 2 g g 5 3 , 6 8


4

8 0 E n c e p h a l i t o z o o n c u n i c o l i U , B / C , T Real-time PCR 1 - 2 g g 5 3 , 6 8

3 4 G e n o t y p i n g G i a r d i a a s s e m b l i e s F C Sequence analysis 1 5 g g 9 3 , 9 4

3 3 G i a r d i a s p p . F C

Real-time TaqMan®

PCR 1 - 2 g g 5 3 , 6 8

4 9 H e l i c o b a c t e r s p p .

B / C a n d g a s t r i c

B A L Real-time PCR 1 - 2 g g 5 3 , 6 8

8 4 H e p a t o z o o n E B , B M Real-time PCR 1 - 2 g g 4 2 . 7 0

2 2 H e r p e s v i r u s B / C , F / V S

Real-time TaqMan®

PCR 1 - 2 g g 4 6 , 9 7

8 7 H i s t o p l a s m a c a p s u l a t u m C o n t a c t l a b PCR 1 - 2 g g 6 1 , 0 0

1

L e i s h m a n i a s p p . B / C , B M , E B

Quantitative PCR

Real-time TaqMan®-

MGB® PCR

1 - 2 g g 4 6 , 9 7

4 L e p t o s p i r o s i s U , B / C , E B

Quantitative real-

time TaqMan® PCR 1 - 2 g g 4 2 . 7 0

7 1 M h a e m a t o p a r v u m ( c a n i n e

h a e m o b a r t o n e l l o s i s ) E B

Real-time TaqMan®-

MGB® PCR 1 - 2 g g 5 3 , 6 8

3 1 M h a e m o c a n i s ( c a n i n e

h a e m o b a r t o n e l l o s i s ) E B

Real-time TaqMan®-

MGB® PCR 1 - 2 g g 5 3 , 6 8

9 6 M y c o b a c t e r i u m s p p E B PCR 1 - 2 g g 1 2 2 , 0 0

7 9 M y c o p l a s m a c a n i s F / V S , C S W Real-time PCR 1 - 2 g g 5 3 , 6 8

7 7 M y c o p l a s m a s p p

F / V S , J F , O S P ,

N S , C S W Real-time PCR 1 - 2 g g 5 3 , 6 8

3 9 N e o s p o r a c a n i n u m T , C S F

Real-time TaqMan®

PCR 1 - 2 g g 4 8 . 8 0

3 8 P a r a i n f l u e n z a N S , O S P , B A L

RT Real-time nested

PCR 1 - 2 g g 5 3 , 6 8

2 0 P a r v o v i r u s E B , F C

Quantitative real-

time PCR 1 - 2 g g 4 6 , 9 7

9 7 P r o t o t h e c a z o p f i i a n d w i c k e r h a m i i E B , F C Real-time PCR 1 - 2 g g 4 6 , 9 7

1 7 R i c k e t t s i a s p p . E B , B / C , C S F

Real-time TaqMan®

PCR 1 - 2 g g 4 6 , 9 7

7 2 S c r e e n i n g - h a e m o b a r t o n e l l o s i s ( M

h a e m o c a n i s , M h a e m a t o p a r v u m ) E B Real-time PCR 1 - 2 g g 8 0 , 5 2

1 3 8 T e n i a c y c l o p h y l l i d e a n E B PCR 1 - 2 g g 4 6 , 9 7

1 3 9 T e n i a H y m e n o l e p i s E B PCR 1 - 2 g g 4 6 , 9 7

9 8 T e n i a s p p F C PCR 1 - 2 g g 4 6 , 9 7

4 0 T y p i n g - P a r v o v i r u s E B , F C Sequence analysis 1 5 g g 9 3 , 9 4

9 9 T y p i n g - f u n g h i E B , F C PCR 1 5 g g 1 2 2 , 0 0

7 T o x o p l a s m a g o n d i i F C , C S F , B / C , A H

Real-time TaqMan®

PCR 1 - 2 g g 4 6 , 9 7

7 3 W o l b a c h i a s p p . E B , B / C

Real-time TaqMan®

PCR 1 - 2 g g 4 0 . 2 6

INFECTIOUS DISEASE PCRS/Cats

T e s t A b b r e v i a t i

o n s Analysis

M a x i m u m

t u r n a r o u n d

t i m e

P r i c e i n

e u r o s V A T

i n c l .

2 8 B a r t o n e l l a s p p . – ( s c r a t c h d e s e a s e ) E B Real-time PCR 1 - 2 g g 4 6 , 9 7

1 2 C a l i c i v i r u s O S P

RT Real-time nested

PCR 1 - 2 g g 5 3 , 6 8

7 5 C a n d . M h a e m o m i n u t u m

( h a e m o b a r t o n e l l o s i s ) E B

Quantitative real-

time TaqMan®-

MGB PCR

1 - 2 g g 5 3 , 6 8


5

7 6 C a n d . M t u r i c e n s i s


Quantitative real-

time TaqMan®-

MGB PCR

1 - 2 g g 5 3 , 6 8

8 C h l a m i d o p h y l a f e l i s C S W , B / C Real-time PCR 1 - 2 g g 4 6 , 9 7

6 0 7 C l o s t r i d i u m b o t u l i n u m c o n t a c t l a b PCR 1 - 2 g g 8 0 , 5 2

1 5 C o r o n a v i r u s F e l i n o ( r i c e r c a m R N A r i f .

S i m o n s e t a l . , 2 0 0 5 ) E B RT real-time PCR 1 - 2 g g 5 3 , 6 8


8 0 E n c e p h a l i t o z o o n c u n i c o l i U , B / C , T Real-time PCR 1 - 2 g g 5 3 , 6 8

1 6 F C O V ( F e l i n e C o r o n a V i r u s ) F C , e f f u s i o n

RT Real-time nested

PCR 1 - 2 g g 5 3 , 6 8

1 3 F E L V ( F e l i n e L e u k e m i a V i r u s ) B / C , B M , E B

Real-time TaqMan®

PCR 1 - 2 g g 4 6 , 9 7

1 4 F I V ( F e l i n e I m m u n o d e f i c i e n c y V i r u s ) B / C , B M , E B Real-time PCR 1 - 2 g g 4 6 , 9 7

3 4 G i a r d i a a s s e m b l a g e s / g e n o t y p i n g F C Sequence analysis 1 5 g g 9 3 , 9 4


Real-time TaqMan®

PCR 1 - 2 g g 5 3 , 6 8

2 3 H e r p e s v i r u s F / V S , E B Real-time PCR 1 - 2 g g 4 6 , 9 7

7 4 M h a e m o f e l i s


Quantitative real-

time TaqMan®-

MGB PCR

1 - 2 g g 5 3 , 6 8

2 1 P a r v o v i r u s ( p a n l e u c o p e n i a ) E B , F C

Quantitative real-

time PCR 1 - 2 g g 4 6 , 9 7

1 1 S c r e e n i n g - h a e m o b a r t o n e l l o s i s ( M

h a e m o f e l i s , M h a e m o m i n u t u m ; M

t u r i c e n s i s )

B / C , B M , E B Real-time PCR 1 - 2 g g 5 3 , 6 8

7 T o x o p l a s m a g o n d i i

F C , C S F ,

B / C , A H

Real-time TaqMan®

PCR 1 - 2 g g 4 6 , 9 7

8 1 T r i t r i c h o m o n a s f o e t u s F C , F S

Real-time nested

PCR 1 - 2 g g 5 3 , 6 8

INFECTIOUS DISEASE PCRS/Horses

T e s t A b b r e v i a t io

n s Analysis

M a x i m u m

t u r n a r o u n d

t i m e

P r i c e i n

e u r o s V A T

i n c l .

5 6 A d e n o v i r u s t y p e 1 B / C , S PCR 1 - 2 g g 5 3 , 6 8

5 7 A d e n o v i r u s t y p e 2 B / C , S PCR 1 - 2 g g 5 3 , 6 8

2 4 A n a p l a s m a p h a g o c y t o p h i l u m E B , B / C , C S F Real-time PCR 1 - 2 g g 5 3 , 6 8

5 8 A r t e r i v i r u s ( i n f e c t i o u s a r t e r i t e )

E B , F / V S , S P ,

B / C , T RT PCR 1 - 2 g g 5 3 , 6 8

2 9 B a b e s i a c a b a l l i E B Real-time PCR 1 - 2 g g 4 8 . 8 0

6 1 C l o s t r i d i u m p i l i f o r m e F C PCR 1 - 2 g g 5 3 , 6 8

6 4 C o r o n a v i r u s F C Real-time PCR 1 - 2 g g 5 3 , 6 8


9 E h r l i c h i a ( A n a p l a s m a ) s p p . E B , B / C , C S F Real-time PCR 1 - 2 g g 5 3 , 6 8

4 7 E H V 1 ( E q u i n e H e r p e s V i r u s 1 )

E B , S , C S F ,

B / C , T

Real-time

TaqMan® PCR 1 - 2 g g 5 3 , 6 8

5 4 E H V 2 ( E q u i n e H e r p e s V i r u s 2 )

E B , S , B A L ,

B / C , T Real-time PCR 1 - 2 g g 5 3 , 6 8

5 3 E H V 3 ( E q u i n e H e r p e s V i r u s 3 ) E B , S , B / C , T Real-time PCR 1 - 2 g g 5 3 , 6 8

4 8 E H V 4 ( E q u i n e H e r p e s V i r u s 4 ) E B , S , B / C , T

Real-time

TaqMan® PCR 1 - 2 g g 5 3 , 6 8

5 5 E H V 5 ( E q u i n e H e r p e s V i r u s 5 ) E B , S , B / C , T Real-time PCR 1 - 2 g g 5 3 , 6 8

3 4 G i a r d i a a s s e m b l a g e s / g e n o t y p i n g F C Sequence analysis 1 5 g g 9 3 , 9 4


6


Real-time

TaqMan® PCR 1 - 2 g g 5 3 , 6 8

6 0 H a b r o n e m a m i c r o s t o m a F C PCR 1 - 2 g g 5 3 , 6 8

5 9 H a b r o n e m a m u s c a e F C PCR 1 - 2 g g 5 3 , 6 8

4 9 H e l i c o b a c t e r s p p .

B / C e g a s t r i c

l a v a g e Real-time PCR 1 - 2 g g 5 3 , 6 8

5 1 I n f l u e n z a A v i r u s E B RT PCR 1 - 2 g g 5 3 , 6 8

4 L e p t o s p i r o s i s U , B / C , E B

Quantitative real-

time TaqMan® PCR 1 - 2 g g 4 2 , 7 0

6 2 R h o d o c o c c u s e q u i

( r o d o c o c c o s i )

F C , S , B / C ,

B A L PCR 1 - 2 g g 5 3 , 6 8

6 5 R o t a v i r u s F C RT PCR 1 - 2 g g 5 3 , 6 8

5 2 S t r e p t o c o c c u s e q u i s u b s p .

z o o e p i d e m i c u s a n d s u b s p . e q u i B / C , F / V S PCR 1 - 2 g g 6 1 , 0 0

6 3 T a y l o r e l l a e q u i g e n i t a l i s F / V S PCR 1 - 2 g g 5 3 , 6 8

3 0 T h e i l e r i a e q u i E B Real-time PCR 1 - 2 g g 4 8 . 8 0

INFECTIOUS DISEASE PCRS/Pigs and Cattle


M a x i m u m

t u r n a r o u n d

t i m e

P r i c e i n

e u r o s V A T

i n c l .

2 4 9 B o v i n e P a p i l l o m a v i r u s E B , S , T PCR 1 - 2 g g 4 6 , 9 7

4 4 P o r c i n e C i r c o v i r u s B / C , E B PCR 1 - 2 g g 4 6 , 9 7

5 P R R S V ( P o r c i n e R e p r o d u c t i v e

R e s p i r a t o r y S y n d r o m e ) B / C , E B , S P RT Real-time PCR 1 - 2 g g 5 3 , 6 8

INFECTIOUS DISEASE PCRS/Birds and Rabbits


M a x i m u m

t u r n a r o u n d

t i m e

P r i c e i n

e u r o s V A T

i n c l .

4 6 C h l a m i d i a p s i t t a c i E B , F C , C S Real-time PCR 1 - 2 g g 4 6 , 9 7

6 9 C i r c o v i r u s P B F D ( P s i t t a c i n e B e a k a n d

F e a t h e r D i s e a s e ) E B , F C , C S , T Real-time PCR 1 - 2 g g 5 3 , 6 8

8 0 E n c e p h a l i t o z o o n c u n i c o l i U R , B / C , T Real-time PCR 1 - 2 g g 5 3 , 6 8

6 7

P s i t t a c i d H e r p e s v i r u s ( P a c h e c o ) E B , F C , C S , T PCR 1 - 2 g g 5 3 , 6 8

6 8 A v i a n P o l y o m a v i r u s E B , F C , C S , T Real-time PCR 1 - 2 g g 5 3 , 6 8

9 1 R H D V C a l i c i v i r u s / R a b b i t s E B , c o n t a c t l a b PCR 1 - 2 g g 4 6 , 9 7

INFECTIOUS DISEASE PCR PROFILES


M a x i m u m

t u r n a r o u n d

t i m e

P r i c e i n

e u r o s V A T

i n c l .

2 0 0 PCR Profile 1A/dogs - “ A r t h r o p o d -

b o r n e d i s e a s e s 1 ”

(Leishmania/Ehrl ichia spp./Ricketts ia

spp.)

B / C , B M , E B Real-time TaqMan®

PCR, Real-time PCR 1 - 2 g g 9 1 , 5 0


7

2 4 6 PCR Profile 1B/ dogs

“ A r t h r o p o d - b o r n e d i s e a s e s 2 ”

(Leishmania/Ehrl ichia canis/Ricketts ia

spp.)

B / C , B M , E B Real-time TaqMan®


2 0 2 PCR P r o f i l e 3 / d o g s “ N e u r o l o g y ”

(Distemper/Toxoplasma/ Neospora

caninum)

C S F , E B

Real-time TaqMan®

PCR, RT Real-time

nested PCR

1 - 2 g g 1 1 5 , 9 0

2 0 4 PCR P r o f i l e 4 / d o g s - “ T i c k - b o r n e

d i s e a s e s ”

(Babesia spp./Ehrl ichia canis /Ricketts ia

spp.)

E B , B / C , C S F Real-time TaqMan®


2 0 3 PCR P r o f i l e 5 / d o g s – “ E x p a n d e d

t i c k - b o r n e d i s e a s e s ”

( Babesia spp./Ehrl ichia canis /Ricketts ia

spp./Borrel ia burgdorferii)

E B , B / C , C S F Real-time TaqMan®

PCR, Real-time PCR 1 - 2 g g 1 0 3 , 7 0

2 0 5 PCR P r o f i l e 6 A / d o g s - “ F i l a r i o s i s ”

(Dirofilaria immitis, Dirofilaria repens) E B , B / C Real-time PCR 1 - 2 g g 4 8 , 8 0

2 4 8 PCR P r o f i l e 6 B / d o g s

“ F i l a r i o s i s n e w p a n e l ”

(Dirofilaria immitis, Wolbachia)

E B

Real-time TaqMan®


2 0 7 PCR P r o f i l e 7 / d o g s - “ I n t e s t i n a l

p r o t o z o o ”

( C r y p t o s p o r i d i u m , G i a r d i a )

F C

Real-time TaqMan®


2 0 8 PCR P r o f i l e 8 / d o g s - “ I n t e s t i n a l ”

( C C O V , P a r v o v i r u s , G i a r d i a ) F C

Real-time TaqMan®

PCR, RT Real-time

PCR

1 - 2 g g 1 0 9 , 8 0

2 0 9 PCR P r o f i l e 9 / d o g s - “ E x p a n d e d

i n t e s t i n a l ”

( C C O V , P a r v o v i r u s , G i a r d i a ,

C r y p t o s p o r i d i u m )

F C

Real-time PCR, RT

Real-time PCR, Real-

time TaqMan® PCR

1 - 2 g g 1 2 2 , 0 0

2 1 0 PCR P r o f i l e 1 0 / d o g s -

“ R e s p i r a t o r y ”

( D i s t e m p e r , C A V 2 , B o r d e t e l l a

b r o n c h i s e p t i c a , P a r a i n f l u e n z a )

E B , B A L , N S , O S P ,

C S W

RT Real-time nested

PCR, Real-time PCR,

RT Real-time PCR

1 - 2 g g 1 2 2 , 0 0

2 1 1 PCR P r o f i l e 1 1 / d o g s - “ Z o o n o s e s /

d o g s ”

( L e p t o s p i r o s i s , G i a r d i a ,

C r y p t o s p o r i d i u m )

F C , U Real-time PCR, real-


2 3 0 PCR P r o f i l e 1 A / c a t s “ N e u r o l o g y 1 ”

( T o x o p l a s m a / F I P ) C S F + E B ; o n l y E B

RT Real-time PCR,

Real-time TaqMan®

PCR

1 - 2 g g 7 9 , 3 0

2 3 9 PCR P r o f i l e 1 B / c a t s “ N e u r o l o g y 2 ”

( T o x o p l a s m a / F C O V ) C S F + E B ; e f f u s i o n

RT Real-time PCR,

Real-time TaqMan®

PCR

1 - 2 g g 7 9 , 3 0

2 3 1 PCR P r o f i l e 2 A / c a t s “ V i r a l d i s e a s e s

1 ”

( F I P / F E L V / F I V )

E B , B M , B / C

RT Real-time PCR,

Real-time TaqMan®

PCR, Real-time PCR

1 - 2 g g

9 7 , 6 0

2 4 0 PCR P r o f i l e 2 B / c a t s “ V i r a l d i s e a s e s

2 ”

( F C O V / F E L V / F I V )

E f f u s i o n ; E B , B M ,

B / C

RT Real-time PCR,

Real-time TaqMan®

PCR, Real-time PCR

1 - 2 g g

9 7 , 6 0

2 3 2 PCR P r o f i l e 3 / c a t s “ A n e m i a ”

( h e m o b a r t o n e l l o s i s

f e l i n e / F E L V / F I V )

B / C , B M , E B Real-time PCR, real-


2 3 3 PCR P r o f i l e 4 / c a t s

“ O p h t h a l m o l o g i c - r e s p i r a t o r y ”

( c a l i c i v i r u s / h e r p e s v i r u s /

C h l a m i d o p h y l a f e l i s )

B / C , C S W , E B RT Real-time nested


2 3 4 PCR P r o f i l e 5 / c a t s “ F i l a r i o s i s ”

( D i r o f i l a r i a i m m i t i s , D i r o f i l a r i a

r e p e n s )

E B , B / C Real-time PCR 1 - 2 g g 4 8 , 8 0

2 3 5 PCR P r o f i l e 6 / c a t s - “ I n t e s t i n a l

p r o t o z o a ”

( C r y p t o s p o r i d i u m , G i a r d i a )

F C Real-time PCR, real-


2 3 6 PCR P r o f i l e 7 / c a t s - “ Z o o n o s e s /

c a t s ”

(Toxoplasmosis, Cryptosporidium,

Giardia, Bartonella spp.)

F C a n d E B Real-time PCR, real-

time TaqMan® PCR 1 - 2 g g 1 0 9 , 8 0

2 3 7 PCR P r o f i l e 8 / c a t s

“ H e m o t r o p i c M y c o p l a s m ”

(M haemophelis, Candidatus M

haemominutum, Candidatus M

turicensis)

E B real-time TaqMan®-

MGB PCR 1 - 2 g g 9 7 , 6 0


8

2 3 8 PCR P r o f i l e P C R 1 / h o r s e s

“ P i r o p l a s i d i ”

(Theileria equi, Babesia caball i)

E B Real-time PCR 1 - 2 g g 6 1 , 0 0

2 4 1 PCR P r o f i l e 2 / h o r s e s

“ R e p r o d u c t i o n ”

(EHV1, Streptococcus equi subsp.

zooepidemicus, Taylorella

equigenitalis,arterite)

F / V S , S P

PCR, RT PCR, real-

time real-time

TaqMan® PCR

1 - 2 g g 1 1 5 , 9 0

2 4 2 PCR P r o f i l e 3 / h o r s e s “ R e s p i r a t o r y ”

(EHV1, EHV4, Rodococcus

equi,Streptococcus equi

subsp.zooepidemicus and equi)

N S , O S P , B A L PCR, real-time

TaqMan® PCR 1 - 2 g g 1 1 5 , 9 0

2 4 3 PCR P r o f i l e 1 / b i r d s

(PBFD,polyomavirus (Pacheco’s

Disease)

E B , F C , C S , T PCR, Real-time PCR 1 - 2 g g 8 5 , 4 0


(PBFD,polyomavirus (Pacheco’s

Disease,Chlamydia psittaci)

E B , F C , C S , T PCR, Real-time PCR 1 - 2 g g 9 1 , 5 0


(PBFD,polyomavirus, Chlamydia psittaci,

genetic sexing)

E B , F C , C S , T Gene scanning,

Real-time PCR 1 5 g g 9 7 , 6 0

GENETIC DISEASES

Matrix analysis for all genetic diseases: EB, 2 X S, 1 X EBS

T e s t B r e e d s Analysis

M a x i m u m

t u r n a r o u n

d t i m e

P r i c e i n

e u r o s V A T

i n c l .

4 6 1 A D - P R A

B u l l m a s t i f f , E n g l i s h M a s t i f f ,

M a s t i f f ( O l d E n g l i s h ) Sequencing 1 5 g g 6 7 , 1 0

5 7 4 A d u l t O n s e t N e u r o p a t h y ( A O N ) * C o c k e r S p a n i e l I n g l e s e Sequencing 1 5 g g 1 0 0 , 0 0

4 9 3

A n a l y s i s S O D 1 g e n e e x o n 2

A l l d o g s b r e e d s Sequencing 5 - 7 g g 3 6 , 6 0

5 5 9 A n a l y s i s S O D 1 g e n e e x o n 1

B e r n e s e M o u n t a i n D o g DHPLC,

Heteroduplex

analysis

1 0 g g 7 3 , 2 0

5 5 5 B e r n a r d S o u l i e r S y n d r o m e ( B S S ) C o c k e r S p a n i e l Sequencing 1 5 g g 6 7 , 1 0

5 1 3 B l o o d G r o u p D N A t e s t

A l l c a t s b r e e d s Serolog test 1 g 3 6 , 6 0

4 9 6 B l o o d G r o u p g e n e t i c t e s t

A l l c a t s b r e e d s ( R a g d o l l

e x c l u d e d )

GeneScanning

+ Sequencing 1 0 g g 6 7 , 1 0

4 2 2 C L A D ( C a n i n e L e u c o c y t e

A d h e s i o n d e f i c i e n c y )

I r i s h S e t t e r Sequencing 1 5 g g 7 3 , 2 0

5 7 7 C M R 1 ( C a n i n e m u l t i f o c a l

r e t i n o p a t h y ) ( d o g s )

A m e r i c a n B u l l d o g ,

A u s t r a l i a n S h e p h e r d ,

B u l l m a s t i f f , C a n e C o r s o ,

D o g u e d e B o r d e a u x ,

E n g l i s h B u l l d o g , E n g l i s h

M a s t i f f , F r e n c h B u l l d o g ,

G r e a t P y r e n e e

Sequencing 1 5 g g 6 7 , 1 0

5 7 8 C M R 2 ( C a n i n e m u l t i f o c a l

r e t i n o p a t h y )

C o t o n d e T u l e a r Sequencing 1 5 g g 6 7 , 1 0

4 4 5 C N M ( H e r e d i t a r y M y o p a t h y ) L a b r a d o r R e t r i e v e r Fragment

analysis 7 g g 4 8 , 8 0

4 5 7 C o a t c o l o u r - A g o u t i A l l c a t s b r e e d s Sequencing 1 0 g g 3 6 , 6 0

5 7 0 C o a t c o l o u r - C h a r c o a l B e n g a l Sequencing 1 0 g g 4 2 , 7 0

4 5 6 C o a t c o l o u r s -

C i n n a m o n / C h o c o l a t e

A l l c a t s b r e e d s Sequencing 1 0 g g 3 6 , 6 0


9

4 5 8 C o a t c o l o u r s - S i a m e s e / B u r m e s e

c a t s


5 4 4 C o a t c o l o u r - A m b r a N o r w e g i a n F o r e s t c a t Sequencing 1 5 g g 4 2 , 7 0

5 2 3 C o a t c o l o u r L o c u s A - A g o u t i

( a l l e l e Y , T A N , N O N A G O U T I )

A l l d o g s b r e e d s Sequencing 1 0 g g 3 6 , 6 0

4 3 3 C o a t c o l o u r L o c u s B

( C h o c o l a t e , B r o w n , … )

A l l d o g s b r e e d s


4 3 2 C o a t c o l o u r L o c u s E ( Y e l l o w ,

A p r i c o t , … )

A l l d o g s b r e e d s Real-time

TaqMan® PCR 5 - 7 g g 3 6 , 6 0

4 9 7 C o a t c o l o u r L o c u s E m

( M e l a n i s t i c M a s k A l l e l e )


5 7 3 C o a t c o l o u r L o c u s H ( H a r e l q u i n

c o a t c o l o u r )

A l l d o g s b r e e d s Sequencing 1 5 g g 3 6 . 6 0

5 2 4 C o a t c o l o u r L o c u s K A l l d o g s b r e e d s Sequencing 1 0 g g 3 6 , 6 0

4 8 6 C o a t c o l o u r T o b i a n o A l l h o r s e s b r e e d s Fragment


5 5 2 C o l l i e E y e A n o m a l y ( C E A ) *


B o r d e r C o l l i e , C o l l i e ,

E n g l i s h S h e p h e r d ,

L a n c a s h i r e H e e i e r ,

M i n i a t u r e A m e r i c a n

S h e p h e r d , M i n i a t u r e


W h i p p e t


6 5 7 C o n j u n c t i v i t i s / L i g n e o u s

m e m b r a n i t i s M a l t e s e Sequencing 1 5 g g 6 7 , 1 0

5 9 4 C o p p e r t o x i c o s i s p r e d i s p o s i t i o n

A T P 7 a

L a b r a d o r r e t r i e v e r Sequencing 1 5 g g 6 7 , 1 0

5 9 5 C o p p e r t o x i c o s i s p r e d i s p o s i t i o n

A T P 7 b

L a b r a d o r r e t r i e v e r Sequencing 1 5 g g 6 7 , 1 0

5 9 1

C o r d 1 - P R A *

M i n i a t u r e D a c h s h u n d s ,

E n g l i s h S p r i n g e r S p a n i e l s ,

C u r l y C o a t e d R e t r i e v e r


5 5 8 C r d - P R A

M i n i a t u r e W i r e h a i r e d

D a c h s h u n d , S t a n d a r d W i r e

h a i r e d D a c h s h u n d


4 3 5 C u r l y A l l d o g s b r e e d s Sequencing 1 5 g g 6 7 , 1 0

4 0 5 C y s t i n u r i a N e w f o u n d l a n d , L a n d s e e r Sequencing 1 5 g g 6 7 , 1 0

5 3 9 C y s t i n u r i a M i n i a t u r e P i n s c h e r Sequencing 1 5 g g 6 7 , 1 0

5 8 8 C y s t i n u r i a A u s t r a l i a n C a t t l e D o g Sequencing 1 5 g g 6 7 , 1 0

6 6 6 D e g e n e r a t i v e M y e l o p a t h y * A l l d o g s b r e e d s 2 1 g g 9 5 , 0 0

6 6 7 D e g e n e r a t i v e M y e l o p a t h y

L a b o k l i n *

A l l d o g s b r e e d s 2 1 g g 1 2 2 , 0 0

6 0 2 D N A B a n k i n g A l l d o g s b r e e d s Storage of a

sample 1 - 2 g g 1 2 , 2 0

4 7 2 D i l u t i o n c o a t c o l o u r s - d o g s A l l d o g s b r e e d s Sequencing 1 0 g g 6 7 , 1 0

4 6 7 D i l u t i o n c o a t c o l o u r s - c a t s A l l c a t s b r e e d s GeneScanning 1 0 g g 4 8 , 8 0

5 2 6 D r y E y e C u r l y C o a t S y n d r o m e

( C C S ) C a v a l i e r K i n g C h a r l e s

S p a n i e l GeneScanning 1 5 g g 6 7 , 1 0

4 5 0 E I C ( E x e r c i s e - I n d u c e d

C o l l a p s e )

L a b r a d o r , P e m b r o k e W e l s h

C o r g i , O l d E n g l i s h

S h e e p d o g , G e r m a n

W i r e h a i r e d P o i n t e r , E n g l i s h

C o c k e r S p a n i e l , C u r l y

C o a t e d R e t r i e v e r ,

C h e s a p e a k e B a y R e t r i e v e r ,

B o y k i n S p a n i e l , B o v a r o

d e l l e f i a n d r e , A m e r i c a n

C o c k e r S p a n i e l

Sequencing 7 - 1 0 g g 7 3 , 2 0


10

4 7 9 E p i d e r m o l y s i s B u l l o s a

J u n c t i o n a l ( E B J )

G e r m a n P o i n t e r , G e r m a n

S h o r t h a i r e d P o i n t e r ,

G e r m a n W i r e h a i r e d

P o i n t e r , G o l d e n R e t r i e v e r

Fragment


5 2 5 E p i s o d i c F a l l i n g ( E F ) * C a v a l i e r K i n g C h a r l e s

S p a n i e l GeneScanning 1 5 g g

6 7 , 1 0

4 0 6 F a c t o r V I I D e f i c i e n c y B e a g l e , A l a s k a n K l e e K a i ,

S c o t t i s h D e e r h o u n d Sequencing 1 5 g g 6 7 , 1 0

4 0 9 F a c t o r X I D e f i c i e n c y K e r r y B l u e T e r r i e r Sequencing 1 5 g g 6 7 , 1 0

4 8 5 F a m i l i a l N e p h r o p a t h y E n g l i s h C o c k e r S p a n i e l Sequencing 1 0 g g 6 7 , 1 0

5 3 8 F o r e n s i c G e n e t i c P r o f i l e C o n t a c t l a b GeneScanning 1 5 g g 1 2 2 , 0 0

4 5 9 F o r e n s i c G e n e t i c P r o f i l e I S A G A l l h o r s e s b r e e d s GeneScanning 1 5 g g 4 8 , 8 0

4 1 0 F u c o s i d o s i s E n g l i s h S p r i n g e r S p a n i e l Sequencing 1 5 g g 6 7 , 1 0

5 3 7 F u r n i s h i n g A l l d o g s b r e e d s Sequencing 1 0 g g 3 6 , 6 0

4 6 8 G a n g l i o s i d o s i s G M 1

B u r m e s e , D o m e s t i c

S h o r t h a i r , S i a m e s e , K o r a t Sequencing 1 5 g g 6 7 , 1 0

4 7 8 G a n g l i o s i d o s i s G M 2 B u r m e s e Sequencing 1 5 g g 6 7 , 1 0


D o m e s t i c S h o r t h a i r Sequencing 1 5 g g 6 7 , 1 0


J a p a n e s e S h o r t h a i r Sequencing 1 5 g g 6 7 , 1 0

5 3 5 G a n g l i o s i d o s i s t y p e 1 G M 1

S h i b a I n u , A l a s k a n H u s k y GeneScanning 1 5 g g 6 7 , 1 0

5 4 0 G a n g l i o s i d o s i s t y p e 1 G M 1 * P o r t u g u e s e W a t e r D o g Sequencing 1 5 g g 6 7 , 1 0

4 6 0 G e n e t i c P r o f i l e p a n e l I S A G A l l c a t s b r e e d s GeneScanning 1 5 g g 4 8 , 8 0

4 6 5 G e n e t i c P r o f i l e p a n e l I S A G 2 0 0 8 A l l d o g s b r e e d s GeneScanning 1 5 g g 4 8 , 8 0

5 8 9 G e n e t i c P r o f i l e * A l l p a r r o t b r e e d s 1 5 g g 4 8 , 8 0

4 2 3 G l y c o g e n S t o r a g e D i s e a s e

( G S D ) t y p e I A


4 1 9 G l y c o g e n S t o r a g e D i s e a s e

( G S D ) t y p e I V N o r w e g i a n F o r e s t c a t s GeneScanning 1 5 g g 6 7 , 1 0

5 2 8 G R P R A 1 G o l d e n R e t r i e v e r Sequencing 1 5 g g 6 7 , 1 0

5 6 4 G R P R A 2 * G o l d e n R e t r i e v e r 1 5 g g 8 5 . 4 0

5 6 8 H e m o p h i l i a B R h o d e s i a n R i d g e b a c k Sequencing 1 5 g g 6 7 . 1 0

4 4 3 H e r e d i t a r y C a t a r a c t s B o s t o n T e r r i e r , A u s t r a l i a n

S h e p h e r d , S t a f f o r d s h i r e

B u l l T e r r i e r

GeneScanning 1 0 g g 7 3 , 2 0

5 2 2 H e r e d i t a r y N a s a l P a r a k e r a t o s i s

( H N P K ) *

L a b r a d o r R e t r i e v e r 1 5 g g 1 3 0 , 5 4

5 0 9 H y p e r c a l e m i c P e r i o d i c

P a r a l y s i s ( H Y P P )

A l l h o r s e s b r e e d s Sequencing 1 5 g g 6 7 , 1 0

5 1 8 H y p e r t r o p h i c C a r d i o m y o p a t h y

( H C M ) A 3 1 P

M a i n e C o o n Real-time

TaqMan® PCR 5 - 7 g g 4 2 , 7 0

4 2 1 H y p e r t r o p h i c C a r d i o m y o p a t h y

( H C M ) A 3 1 P e A 7 4 T

M a i n e C o o n Sequencing 1 5 g g 5 4 , 9 0

4 5 4 H y p e r t r o p h i c C a r d i o m y o p a t h y R a g d o l l Real-time

TaqMan® PCR 5 - 7 g g 4 2 , 7 0

5 7 6 H y p e r u r i c o s u r i a A l l d o g s b r e e d s Sequencing 1 5 g g 6 7 , 1 0

4 1 1 H y p o t h y r o i d i s m F o x T e r r i e r GeneScanning 1 5 g g 6 7 , 1 0

5 4 3 I c h t h y o s i s G o l d e n r e t r i e v e r Sequencing 1 5 g g 6 7 , 1 0

5 4 2 I m e r s l u n d - G r ä s b e c k s y n d r o m e

( I G S ) B e a g l e GeneScanning 1 0 g g 7 3 , 2 0

5 8 5 I m e r s l u n d - G r ä s b e c k s y n d r o m e

( I G S ) B o r d e r C o l l i e GeneScanning 1 0 g g 6 7 , 1 0

5 8 2

J u v e n i l e L a r y n g e a l P a r a l y s i s

a n d P o l y n e u r o p a t h y ( J L P P )

R o t t w e i l e r , B a l c k R u s s i a n

T e r r i e r Sequencing 1 5 g g 7 3 , 2 0

5 0 8 J u v e n i l e E p i l e p s y ( J E ) L a g o t t o R o m a g n o l o DHPLC,

Heteroduplex 7 g g 6 7 , 1 0


11

analysis

5 6 7 J u v e n i l e M y o c l o n i c E p i l e p s y

( J M E )

R h o d e s i a n R i d g e b a c k Sequencing 1 5 g g 6 7 , 1 0

4 7 6 L - 2 - H G A ( h y d r o x y g l u t a r i c

a c i d u r i a )

S t a f f o r d s h i r e B u l l T e r r i e r Sequencing 1 0 g g 6 7 , 1 0

5 8 0 L a t e o n s e t a t a x i a ( L O A )

J a c k R u s s e l l T e r r i e r , P a r s o n

R u s s e l l T e r r i e r Sequencing 1 5 g g 7 3 , 2 0

4 9 4 L o n g c o a t d i s e a s e

A l l d o g s b r e e d s ( t h a n f o r

E u r a s i e r , A k i t a , A f g h a n

h o u n d )

GeneScanning


4 5 5 L o n g c o a t d i s e a s e A l l c a t s b r e e d s GeneScanning


5 4 5 L y s o s o m a l s t o r a g e d i s e a s e

( L S D )

L a g o t t o r o m a g n o l o Sequencing 1 0 g g 6 7 , 1 0

5 8 6 M a c r o t h r o m b o c y t o p e n i a C a v a l i e r K i n g C h a r l e s Sequencing 1 5 g g 6 7 , 1 0

4 4 4

M D R 1 G e n e D e f e c t ( I v e r m e c t i n

S e n s i t i v i t y )


B o b t a i l , B o r d e r C o l l i e ,

G e r m a n S h e p h e r d , L o n g -

/ S h o r t h a i r C o l l i e ,

L o n g h a i r e d W h i p p e t ,

M c N a b , S h e t l a n d

S h e e p d o g , S i l k e n

W i n d h o u n d , W h i t e

S h e p h e r d

GeneScanning 7 - 1 0 g g 7 3 , 2 0

5 5 0 M a l i g n a n t H y p e r t h e r m i a ( R Y R )

L a b r a d o r R e t r i e v e r ,

P o i n t e r , G r e y H o u n d Sequencing 1 5 g g 7 3 , 2 0

4 2 0 M a n n o s i d o s i s P e r s i a n GeneScanning 1 5 g g 6 7 , 1 0

4 2 7 M u s c u l a r d y s t r o p h y L a n d s e e r Sequencing 1 5 g g 6 7 , 1 0

5 7 5 M u s c u l a r d y s t r o p h y G o l d e n R e t r i e v e r Sequencing 1 5 g g 6 7 , 1 0

4 3 4 M u s c u l a r d y s t r o p h y

C a v a l i e r K i n g C h a r l e s

S p a n i e l Sequencing 1 5 g g 6 7 , 1 0

5 3 2 M y o t o n i a C o n g e n i t a A u s t r a l i a n C a t t l e D o g Sequencing 1 5 g g 7 3 , 2 0

4 1 5 M y o t o n i a C o n g e n i t a M i n i a t u r e S c h n a u z e r Sequencing 1 5 g g 6 7 , 1 0

4 1 2 M u c o p o l y s a c c h a r i d o s i s ( M P S )

I I I B S c h i p p e r k e Sequencing 1 5 g g 6 7 , 1 0


V I M i n i a t u r e P i n s c h e r S e q u e n c i n g 1 5 g g 6 7 , 1 0


V I S i a m e s e , D o m e s t i c

S h o r t h a i r S e q u e n c i n g 1 5 g g 6 7 , 1 0


V I I D o m e s t i c S h o r t h a i r Sequencing 1 5 g g 6 7 , 1 0


V I I G e r m a n S h e p h e r d , M i x e d

b r e e d Sequencing 1 5 g g 6 7 , 1 0

5 1 5 M u s l a d i n - L u e k e S y n d r o m e ( M L S ) B e a g l e Sequencing 1 5 g g 6 7 , 1 0

5 9 2 M y o s t a t i n D e f i c i e n c y * W h i p p e t 1 5 g g 7 3 , 2 0

5 7 9 N a r c o l e p s y D a c h s h u n d Sequencing 1 5 g g 6 7 , 1 0

5 9 0 N a r c o l e p s y D o b e r m a n n Sequencing 1 5 g g 6 7 , 1 0

5 3 4 N a r c o l e p s y L a b r a d o r R e t r i e v e r Sequencing 1 5 g g 6 7 , 1 0

5 2 7 N e o n a t a l C e r e b e l l a r C o r t i c a l

D e g e n e r a t i o n ( N C C D )

B e a g l e GeneScanning 1 5 g g 6 7 , 1 0

5 3 3 N e u r o n a l C e r o i d L i p o f u s c i n o s i s

5 ( N C L - 5 )

B o r d e r C o l l i e Sequencing 1 5 g g 6 7 , 1 0


8 ( N C L - 8 )

E n g l i s h S e t t e r Sequencing 1 5 g g 6 7 , 1 0


( N C L - A ) *

A m e r i c a n S t a f f o r d s h i r e

T e r r i e r 1 5 g g 6 7 , 1 0

4 3 9 O s t e o c h o n d r o d y s t r o p h i a

d e f o r m a n s


5 3 2 O s t e o g e n e s i s I m p e r f e c t a D a c h s h u n d Sequencing 1 5 g g 6 7 , 1 0

5 1 0 O v e r o L e t h a l W h i t e F o a l A l l h o r s e s b r e e d s Sequencing 1 5 g g 6 7 , 1 0


12

S y n d r o m e ( O L W S )

4 1 6

P h o s p h o f r u c t o k i n a s e d e f i c i e n c y

( P F K D )

A m e r i c a n C o c k e r S p a n i e l ,

E n g l i s h C o c k e r S p a n i e l ,

E n g l i s h S p r i n g e r S p a n i e l ,

W h i p p e t


4 2 9 P i t u i t a r y D w a r f i s m

G e r m a n S h e p h e r d ,

C z e c h o s l o v a k i a n W o l f d o g ,

S a a r l o o s W o l f d o g

GeneScanning 1 0 g g 6 7 , 1 0

4 1 7 P K D e f i c i e n c y ( P y r u v a t e K i n a s e

D e f i c i e n c y )

B e a g l e , L a b r a d o r , P u g Sequencing 1 0 g g 6 7 , 1 0



B a s e n j i Sequencing 1 0 g g 6 7 , 1 0


D e f i c i e n c y ) W e s t H i g h l a n d W h i t e

T e r r i e r Sequencing 1 0 g g 6 7 , 1 0

4 5 3

P K D e f i c i e n c y ( P y r u v a t e K i n a s e


A b y s s i n i a n , B e n g a l a ,

D o m e s t i c S h o r t h a i r ,

D o m e s t i c L o n g h a i r ,

E g y p t i a n M a u , L a P e r m ,

M a i n e c o o n , N o r w e g i a n

F o r e s t , O c i c a t , S a v a n n a h ,

S i b e r i a n , S i n g a p u r a , S o m a l i


4 0 0 P o l y c y s t i c K i d n e y D i s e a s e

( P K D )

A n g o r a , B i r m a n , B r i t i s h

S h o r t - e L o n g h a i r ,

C h a r t r e u x , C o l o u r p o i n t ,

E x o t i c S h o r t h a i r , M a i n e

C o o n , P e r s i a n a n d r e l a t e d

b r e e d s , R a g d o l l , S c o t t i s h

F o l d , S e l k i r k R e x , S i a m e s e

R e a l - t i m e

T a q M a n ®

P C R

5 - 7 g g 3 6 , 6 0

5 9 6 P o l y n e u r o p a t h y * G r e y h o u n d 1 5 g g 6 7 , 1 0

5 1 9 P r o g r e s s i v e r e t i n a l a t r o p h y

( p r c d - P R A ) *

A l l d o g s b r e e d s 1 5 g g 9 5 , 0 0

5 6 0 P R A 1 P a p i l l o n Sequencing 1 5 g g 7 3 , 2 0

4 6 3 P R A - r c d 1 I r i s h s e t t e r Sequencing 1 5 g g 1 4 6 , 4 0

4 6 4 P R A - r c d 3 C a r d i g a n W e l s h C o r g i GeneScanning 1 5 g g 1 4 6 , 4 0

5 8 4 P R A g e n e r a l i z e d * S c h a p e n d o e s 1 5 g g 7 0 , 0 0

6 5 8 P r i m a r y o p e n a n g l e g l a u c o m a

( P O A G )

B a s s e t F a u v e PCR 1 5 g g 6 7 , 1 0


( P O A G )

B a s s e t H o u n d PCR 1 5 g g 6 7 , 1 0


( P O A G )

B e a g l e PCR 1 5 g g 6 7 , 1 0

5 0 6 P r i m a r y L e n s L u x a t i o n ( P L L )

A m e r . E s k i m o D o g , A m e r .

H a i r l e s s T e r r i e r , A u s t r .

C a t t l e D o g , C h i n e s e

C r e s t e d D o g , C h i n e s e F o o

D o g , F o x T e r r i e r , J a c k

R u s s e l l T e r r i e r , J a g d t e r r i e r ,

L a k e l a n d T e r r i e r ,

L a n c a s h i r e H e e l e r , L u c a s

T e r r i e r , M i n i a t u r e B u l l

T e r r i e r , N o r f o l k T e r r i e r ,

N o r w i c h T e r r i e r , P a r s o n

R u s s e l l T e r r i e r , P a t t e r d a l e

T e r r i e r , P u g D o g , R a t

T e r r i e r , S e a l y h a m T e r r i e r ,

T e d d y R o o s e v e l t T e r r i e r ,

T e n t e r f i e l d T e r r i e r , T i b e t

T e r r i e r , T o y F o x T e r r i e r ,

I t a l i a n F o x T e r r i e r , W e l s h

T e r r i e r , W e s t p h a l i a T e r r i e r ,

Y o r k s h i r e T e r r i e r

D H P L C ,

H e t e r o d u p l e

x a n a l y s i s

7 g g 6 7 , 1 0


13

4 7 1 P r o g r e s s i v e R e t i n a l A t r o p h y

( r d A c )

A b y s s i n i a n , A m e r i c a n C u r l ,

A m e r i c a n W i r e h a i r ,

B a l i n e s e , B e n g a l ,

C o l o r p o i n t S h o r t h a i r ,

C o r n i s h R e x , J a v a n e s e ,

M u n c h k i n , O c i c a t , O r i e n t a l

S h o r t h a i r , P e t e r b a l d ,

S i a m e s e , S i n g a p u r a ,

S o m a l o , T o n k i n e s e

S e q u e n c i n g 1 5 g g 6 7 , 1 0

4 2 6 R D Y E a r l y O n s e t w i t h D y s p l a s i a A b y s s i n i a n Sequencing 1 5 g g 6 7 , 1 0

4 4 6 R e n a l C y s t a d e n o c a r c i n o m a G e r m a n S h e p h e r d Sequencing 1 5 g g 7 3 , 2 0

5 4 8 R e s i s t a n c e t o p h e n o b a r b i t o l

g e n e A B C B 1

C o n t a c t l a b Sequencing 1 5 g g 7 3 , 2 0

5 5 6 R e s e a r c h g e n e t i c m a r k e r B l u e

M e r l e

A l l d o g s b r e e d s Fragment

analysis 1 5 g g 7 3 , 2 0

4 0 1 S e x d e t e r m i n a t i o n

A l l p a r r o t b r e e d s Genescanning 1 5 g g 4 6 , 9 7

4 1 8 S e v e r e C o m b i n e d I m m u n e -

d e f i c i e n c y ( S C I D ) W e l s h c o r g i GeneScanning 1 5 g g 6 7 , 1 0

6 2 0 S e v e r e C o m b i n e d I m m u n e -

d e f i c i e n c y ( S C I D ) A l l h o r s e s b r e e d s Sequencing 1 5 g g 6 7 , 1 0

5 7 2 S k e l e t a l D y s p l a s i a 2 L a b r a d o r R e t r i e v e r GeneScanning 1 5 g g 6 7 , 1 0

5 1 1 S h o r t T a i l ( B o b t a i l )

A u s t r a l i a n s h e p h e r d ,

A u s t r i a n P i n s c h e r ,

A u s t r a l i a n S t u m p y T a i l

C a t t l e D o g , B o u r b o n n a i s

P o i n t e r , B r a z i l i a n T e r r i e r ,

B r i t t a n y S p a n i e l , C r o a t i a n

S h e e p d o g , D a n i s h

F a r m d o g , S w e d i s h

F a r m d o g , J a c k R u s s e l l

T e r r i e r , K a r e l i a n B e a r D o g ,

M u d i , P o l i s h L o w l a n d

S h e e p d o g , P y r e n e a n

S h e p h e r d , S a v o y

S h e e p d o g , S c h i p p e r k e ,

S p a n i s h W a t e r D o g ,

S w e d i s h V a l l h u n d


4 9 5 S p i n a l M u s c u l a r A t r o p h y ( S M A )

M a i n e C o o n Sequencing 7 g g 4 8 , 8 0

5 8 1 S p i n o c e r e b e l l a r a t a x i a ( S C A )

J a c k R u s s e l l T e r r i e r , P a r s o n

R u s s e l l T e r r i e r , T e n t e r f i e l d

T e r r i e r , T o y F o x T e r r i e r ,

S m o o t h h a i r e d f o x t e r r i e r


5 3 1 T r a p p e d N e u t r o p h i l S y n d r o m e

( T N S )

B o r d e r C o l l i e Sequencing 1 5 g g 6 7 , 1 0

4 7 7 T h r o m b o p a t h y B a s s e t H o u n d Genescanning 1 5 g g 6 7 , 1 0

4 7 7 T h r o m b o p a t h y E s k i m o S p i t z Sequencing 1 5 g g 6 7 , 1 0

5 4 1 T h r o m b o p a t h y L a n d s e e r Sequencing 1 5 g g 6 7 , 1 0

4 4 7 V o n W i l l e b r a n d d i s e a s e t y p e I

D o b e r m a n , B e r n e s e , C o t o n

d e T u l e r , P i n s c h e r , K e r r y

B l u e T e r r i e r , M a n c h e s t e r

T e r r i e r , P e m b r o k e W e l s h

C o r g i , P o o d l e , S h e t l a n d

s h e e p d o g

Genotyping

TaqMan®MGB 5 - 7 g g 7 3 , 2 0

4 4 8 V o n W i l l e b r a n d d i s e a s e t y p e I I

D e u t s c h D r a h t h a a r ,

G e r m a n S h o r t h a i r e d

P o i n t e r , G e r m a n

W i r e h a i r e d P o i n t e r


4 4 9 V o n W i l l e b r a n d d i s e a s e t y p e I I I S c o t t i s h T e r r i e r GeneScanning 1 5 g g 7 3 , 2 0

4 6 6 V o n W i l l e b r a n d d i s e a s e t y p e I I I S h e t l a n d S h e e p d o g GeneScanning 1 5 g g 7 3 , 2 0

4 4 1 X - l i n k e d P R A 1 S a m o y e d , S . H u s k y GeneScanning 1 5 g g 1 4 6 , 4 0

TaqMan® is a registered trademark of the Roche Molecular System


14

GENETIC DISEASE PROFILES for Dogs and Cats

T e s t

M a x i m u m

t u r n a r o u n

d t i m e

P r i c e i n

e u r o s V A T

i n c l .

P r o f i l e A u s t r a l i a n S h e p e r d

( C E A * + S o d 1 G e n e E x o n 2 + M D R 1 + P r c d - P R A + M a l i g n a n t H y p e r t h e r m i a

+ h e r e d i t a r y c a t a r a c t )

1 5 g g 1 8 0 , 0 0

P r o f i l e - L a g o t t o R o m a g n o l o ( J u v e n i l e e p i l e p s y ( J E ) + L y s o s o m a l S t o r a g e

D i s e a s e ( L S D ) + F u r n i s h i n g ) 5 - 7 g g 1 1 0 , 0 0

P r o f i l e - B e a g l e

( M u s l a d i n L u e k e S y n d r o m e ( M L S ) + F a c t o r V I I D e f i c i e n c y + N e o n a t a l

C e r e b e l l a r C o r t i c a l D e g e n e r a t i o n ( N C C D ) + P O A G + I G S + P K D e f i c i e n c y )

1 5 g g 1 2 6 , 0 0

P r o f i l e - S a a r l o o s W o l f d o g

( S o d 1 G e n e E x o n 2 + D w a r f i s m ) 1 5 g g 1 2 6 , 0 0

P r o f i l e - D o b e r m a n n 1

( S o d 1 G e n e E x o n 2 + C o a t d i l u t i o n + V o n W i l l e b r a n I D i s e a s e ) 1 5 g g 1 2 6 , 0 0


( C o a t d i l u t i o n + V o n W i l l e b r a n I D i s e a s e ) 1 5 g g 9 1 , 5 0


( C o a t d i l u t i o n + V o n W i l l e b r a n I D i s e a s e + L o c u s B ) 1 5 g g 1 2 6 , 0 0

P r o f i l e - L u p o C e c o s l o v a c c o 1

( S o d 1 G e n e E x o n 2 + D w a r f i s m ) 1 5 g g 8 5 , 0 0

P r o f i l e - L u p o C e c o s l o v a c c o 2

( S o d 1 G e n e E x o n 2 + D w a r f i s m + L o n g c o a t d i s e a s e ) 1 5 g g 1 1 0 , 0 0

P r o f i l e - C a v a l i e r K i n g C h a r l e s S p a n i e l - D r y E y e C u r l y C o a t S y n d r o m e

( C C S ) + E p i s o d i c F a l l i n g ( E F ) 1 5 g g 8 5 , 0 0

P r o f i l e - E n g l i s h C o c k e r S p a n i e l ( F a m i l i a l N e p h r o p a t h y ( F N ) + P r c d - P R A* +

B e r n a r d S o u l i e r S y n d r o m e ( B S S ) ) 1 5 g g 1 6 5 , 0 0

P r o f i l e - G o l d e n R e t r i e v e r ( G R P R A 1 + G R P R A 2 * + P r c d - P R A * + S o d 1 G e n e

E x o n 2 + I c h t h y o s i s ) 1 5 g g 1 8 0 , 0 0

P r o f i l e - L a b r a d o r R e t r i e v e r ( C N M + S o d 1 G e n e E x o n 2 + E I C + H N P K * +

P r c d - P R A * + D w a r f i s m S D 2 ) 1 5 g g 1 8 0 , 0 0

P r o f i l e C o l l i e

( G e n e S o d 1 E x o n 2 + C E A * + M D R 1 ) 1 5 g g 1 2 6 , 0 0

P r o f i l e - B o r d e r C o l l i e

( S o d 1 G e n e E x o n 2 + M D R 1 + C E A * + I G S + N C L + T N S ) 1 5 g g 1 2 6 , 0 0

P r o f i l e - A u s t r a l i a n S h e p h e r d

( C E A * + S o d 1 G e n e E x o n 2 + h e r e d i t a r y c a t a r a c t + M D R 1 + M a l i g n a n t

H y p e r t h e r m i a + P r c d - P R A * )

1 5 g g 1 8 0 , 0 0

P r o f i l e - S c h i p p e r k e 1

( M D R 1 + M P S I I I B + S o d 1 G e n e E x o n 2 + P r c d - P r a * + B o b t a i l + D N A

B a n k i n g )

1 5 g g 2 2 0 , 0 0


( M D R 1 + M P S I I I B )

1 5 g g 1 1 0 , 0 0


( M D R 1 + M P S I I I B + D N A B a n k i n g )

1 5 g g 1 1 5 , 0 0

P r o f i l e R h o d e s i a n R i d g e b a c k

( S o d 1 G e n e E x o n 2 + + J M E + H e m o p h i l i a B ) 1 5 g g 1 1 0 , 0 0

P r o f i l e S t a f f o r d s h i r e B u l l T e r r i e r

( L 2 H 2 + H e r e d i t a r y C a t a r a c t s ) 1 5 g g 1 1 0 , 0 0

P r o f i l e L a n d s e e r

( S o d 1 G e n e E x o n 2 + M u s c u l a r d y s t r o p h y + T h r o m b o p a t h y + C y s t i n u r i a ) 1 5 g g 1 2 6 , 0 0

G e n e t i c p r o f i l e 1 - c a t s

P K D + P K D e f + H C M 1 m u t a t i o n ( M a i n e C o o n o r R a g d o l l ) 1 5 g g 1 1 0 , 0 0


P K D e f + P K D + S p i n a l M u s c u l a r A t r o p h y ( S M A) 1 5 g g 1 2 0 , 0 0


15


S e r o l o g i c b l o o d t y p e g r o u p i n g + g e n e t i c b l o o d g r o u p t y p i n g 1 5 g g 9 5 , 0 0

*Test carried out at a partner laboratory

URGENCY: test carried out in 5 working days (+ 30% over the cost of the analysis). Analyses sent to partner laboratories are excluded.

VETERINARY MOLECULAR-ONCOLOGY DESEASES


M a x i m u m

t u r n a r o u n d

t i m e

P r i c e i n

e u r o s

V A T

i n c l .

6 1 1 M i n i m a l r e s i d u a l d i s e a s e ( M R D ) B / C , B M , E B Real-time P C R 2 g g 4 6 , 9 7

6 1 6 C l o n a l i t y t e s t - B a n d T c e l l r e c e p t o r s –

c a t s B / C , B M , E B

P C R +

G e n e s c a n n i n g 1 5 g g 1 2 2 , 0 0

4 0 3 C l o n a l i t y t e s t - B a n d T c e l l r e c e p t o r s -

d o g s B / C , B M , E B

P C R +

G e n e S c a n n i n g 1 5 g g 1 2 2 , 0 0

4 4 2 I T D c - k i t P o i n t M u t a t i o n e x o n 1 1 i n

c a n i n e m a s t o c y t o m a ( I T D , i n s e r t i o n s

a n d d e l e t i o n s )

B / C , E B P C R +

G e n e S c a n n i n g 1 0 g g 8 5 , 4 0

4 7 3 I T D c - k i t P o i n t M u t a t i o n e x o n 8 i n

c a n i n e m a s t o c y t o m a B / C , E B

P C R +

G e n e S c a n n i n g +

S e q u e n c i n g

1 0 g g 8 5 , 4 0

4 7 4 I T D c - k i t P o i n t M u t a t i o n e x o n 9 i n

c a n i n e m a s t o c y t o m a B / C , E B P C R + S e q u e n c i n g 1 0 g g 8 5 , 4 0


c a n i n e m a s t o c y t o m a B / C , E B P C R + S e q u e n c i n g 1 0 g g 8 5 , 4 0

4 7 5 P a n e l o f c - k i t r e c e p t o r m u t a t i o n s -

c a n i n e m a s t o c y t o m a e x o n s 8 , 9 , 1 1 , 1 7 B / C , E B

P C R +


S e q u e n c i n g

1 5 g g 1 4 6 , 4 0


f e l i n e m a s t o c y t o m a ( I T D , i n s e r t i o n s a n d

d e l e t i o n s )

B / C , E B

P C R +


s e q u e n c i n g

1 0 g g 8 5 , 4 0

4 9 9 I T D c - k i t P o i n t M u t a t i o n e x o n 8 i n f e l i n e

m a s t o c y t o m a ( I T D , i n s e r t i o n s a n d

d e l e t i o n s )

B / C , E B P C R + S e q u e n c i n g 1 0 g g 8 5 , 4 0

5 0 4 I T D c - k i t P o i n t M u t a t i o n e x o n 9 i n f e l i n e

m a s t o c y t o m a ( I T D , i n s e r t i o n s a n d

d e l e t i o n s )

B / C , E B P C R + S e q u e n c i n g 1 0 g g 8 5 , 4 0

5 0 5 P a n e l o f c - k i t r e c e p t o r m u t a t i o n s - f e l i n e

m a s t o c y t o m a e x o n s 8 , 9 , 1 1 B / C , E B

P C R +


S e q u e n c i n g

1 5 g g 1 4 6 , 4 0

6 1 2 C l o n a l i t y t y p i n g B / C , B M , E B S e q u e n c i n g 1 5 g g 9 3 , 9 4

6 6 8 M u t a t i o n g e n e b r a f o f t r a n s i t i o n a l c e l l s

i n t h e u r i n a r y b l a d d e r B / C , E B P C R + S e q u e n c i n g 1 5 g g 6 7 , 1 0

URGENZA: test carried out in 5 working days (+ 30% over the cost of the analysis). Analyses sent to partner laboratories are excluded.

SEROLOGY-IMMUNOFLUORESCENCE DISEASES


M a x i m u m

t u r n a r o u n d

t i m e

P r i c e i n

e u r o s V A T

i n c l .

3 1 0 A n a t e s t S E , P L I F A 1 g 3 6 , 6 0

1 0 9 A n a p l a s m a p h a g o c y t o p h i l u m ( H G E )

I g G S E , P L I F A 1 g 3 6 , 6 0


16

1 1 0 A n a p l a s m a p h a g o c y t o p h i l u m ( H G E )

I g M S E , P L I F A 1 g 3 6 , 6 0

1 0 3 B a b e s i a c a b a l l i I g G S E , P L I F A 1 g 3 6 , 6 0

1 1 7 B a b e s i a c a b a l l i I g M S E , P L I F A 1 g 3 6 , 6 0

1 1 5 B a b e s i a c a n i s I g G S E , P L I F A 1 g 3 6 , 6 0

1 0 2 B a b e s i a e q u i I g G S E , P L I F A 1 g 3 6 , 6 0

1 0 6 B a b e s i a e q u i I g M S E , P L I F A 1 g 3 6 , 6 0

2 5 1 B a b e s i a m d r i I g G S E , P L I F A 1 g 3 6 , 6 0

2 5 2 B a b e s i a g i b s o n i I g M S E , P L I F A 1 g 3 6 , 6 0

1 2 7 B a r t o n e l l a h e n s e l a e I g G S E , P L I F A 1 g 3 6 , 6 0

1 3 0 B a r t o n e l l a h e n s e l a e I g M S E , P L I F A 1 g 3 6 , 6 0

1 0 4 B o r r e l i a b u r g d o r f e r i i I g G S E , P L I F A 1 g 3 0 , 5 0

1 0 5 B o r r e l i a b u r g d o r f e r i i I g M S E , P L I F A 1 g 3 0 , 5 0

1 3 2 C a n i n e H e r p e s v i r u s I g G S E , P L I F A 1 g 4 8 , 8 0

1 1 8 D i s t e m p e r I g G S E , P L , C S F I F A 1 g 3 6 , 6 0

1 1 9 D i s t e m p e r I g M S E , P L , C S F I F A 1 g 3 6 , 6 0

1 0 7 E h r l i c h i a c a n i s I g G S E , P L I F A 1 g 3 6 , 6 0

1 0 8 E h r l i c h i a c a n i s I g M S E , P L I F A 1 g 3 6 , 6 0

1 3 3 E q u i n e H e r p e s v i r u s 1 , 4 I g G S E , P L I F A 1 g 4 8 , 8 0

1 1 6 F I P V I g G S E , P L I F A 1 g 3 0 , 5 0

1 0 1 L e i s h m a n i a I g G S E , P L I F A 1 g 3 1 , 7 2

1 2 2 N e o r i c k e t t s i a r i s t i c i i I g G S E , P L I F A 1 g 3 6 , 6 0

1 1 3 N e o s p o r a c a n i n u m I g G S E , P L I F A 1 g 3 6 , 6 0

1 1 4 N e o s p o r a c a n i n u m I g M S E , P L I F A 1 g 3 6 , 6 0

1 2 8 C a n i n e P a r v o v i r u s I g G S E , P L I F A 1 g 3 6 , 6 0

1 3 1 R i c k e t t s i a c o n o r i i I g G S E , P L I F A 1 g 3 0 , 5 0

1 3 4 R i c k e t t s i a c o n o r i i I g M S E , P L I F A 1 g 3 0 , 5 0

1 2 0 R i c k e t t s i a r i c k e t t s i i I g G S E , P L I F A 1 g 3 0 , 5 0

1 2 1 R i c k e t t s i a r i c k e t t s i i I g M S E , P L I F A 1 g 3 0 , 5 0

1 1 1 T o x o p l a s m a g o n d i i I g G S E , P L I F A 1 g 3 0 , 5 0

1 1 2 T o x o p l a s m a g o n d i i I g M S E , P L I F A 1 g 3 0 , 5 0

SEROLOGY-IMMUNOFLUORESCENCE PROFILE DISEASES


M a x i m u m

t u r n a r o u n d

t i m e

P r i c e i n

e u r o s V A T

i n c l .

3 0 4 D i s t e m p e r I g G - I g M S E , P L I F A 2 g g 6 4 , 0 5

3 0 5 N e o s p o r a c a n i n u m I g G - I g M S E , P L I F A 2 g g 6 4 , 0 5

3 5 4 S e r o l o g y p r o f i l e “ V a c c i n a t i o n / d o g s ”

P a r v o v i r u s – D i s t e m p e r I g G S E , P L I F A 2 g g 6 4 , 0 5

3 0 1 S e r o l o g y p r o f i l e 1 / d o g s “ A r t h r o p o d -

b o r n e d i s e a s e s ”

( L e i s h m a n i a , E h r l i c h i a c a n i s , R i c k e t t s i a

r i c k e t t s i i )

S E , P L I F A 2 g g 8 7 , 8 4

3 0 2

S e r o l o g y p r o f i l e 2 / d o g s “ T i c k - b o r n e

d i s e a s e s ”

( B a b e s i a c a n i s / E h r l i c h i a c a n i s /

R i c k e t t s i a r i c k e t s i i )

S E , P L I F A 2 g g 8 7 , 8 4

3 0 3

S e r o l o g y p r o f i l e 3 / d o g s “ N e u r o l o g i c a l ”

( D i s t e m p e r , T o x o p l a s m a g o n d i i ,

N e o s p o r a c a n i n u m )

S E , P L

I F A

2 g g

8 7 , 8 4


17

3 5 1 S e r o l o g y p r o f i l e 1 A / h o r s e s

“ P i r o p l a s m o s i s ”

( B a b e s i a e q u i I g G , B a b e s i a c a b a l l i I g G )

S E , P L I F A 2 g g 6 4 , 0 5

3 3 1 S e r o l o g y p r o f i l e 1 B / h o r s e s

“ P i r o p l a s m o s i s 2 ”

( B a b e s i a e q u i I g G e I g M , B a b e s i a

c a b a l l i I g G a n d I g M )

S E , P L I F A 2 g g 9 1 , 5 0

3 5 2 S e r o l o g y p r o f i l e 2 / h o r s e s “ T i c k - b o r n e

d i s e a s e s ”

( B a b e s i a e q u i I g G , B a b e s i a c a b a l l i I g G ,

A n a p l a s m a p h a g o c y t o p h i l u m I g G )

S E , P L I F A 2 g g 8 8 , 6 9

3 0 6 T o x o p l a s m a g o n d i i I g G - I g M S E , P L I F A 2 g g 5 1 , 2 4

price list 2018 - genefast

Documents